Table S1.
Summary of the basic characteristics of patients
| Citation | Sex | Age | Malignant solid tumor | Location of EMH | Hematopathy | Therapy of EMH | Outcome |
|---|---|---|---|---|---|---|---|
| Meykler et al1 | M | 64 | Renal cancer | Pleura | N | None | NA |
| Bowen et al2 | F | 72 | Breast cancer | lymph nodes | Y | Surgery | DOM |
| Pantanow et al3 | M | 47 | Kaposi’s sarcoma | Pleura | Y | None | SD |
| Takhar et al4 | F | 53 | Breast cancer | lymph nodes | N | Surgery | SD |
| Ardakani et al5 | F | 44 | EAS | Peritoneum | N | Surgery | SD |
| Ardakani et al5 | F | 30 | EAS | Peritoneum | N | Surgery | SD |
| Ardakani et al5 | F | 56 | OLMS | Peritoneum | N | Surgery | SD |
| Ardakani et al5 | F | 37 | OEC | Peritoneum | N | Surgery | SD |
| Wang et al6 | F | 43 | Breast cancer | Breast | N | Surgery | NA |
| Wang et al6 | F | 38 | Breast cancer | Breast | N | Surgery | NA |
| Tokumitsu et al7 | M | 52 | Lung cancer | Paraspinal region | Y | Blood transfusion | DOM |
| Yablonski-Peretz et al8 | F | 43 | Breast cancer | Liver | Y | Blood transfusion | DOM |
| Lemos et al9 | F | 50 | Adrenal cancer | Liver | Y | None | NA |
| Prieto-Granada et al10 | F | 41 | Breast cancer | lymph nodes | N | Surgery | NA |
| Prieto-Granada et al10 | F | NA | Breast cancer | lymph nodes | N | Surgery | NA |
| Prieto-Granada et al10 | F | 47 | Breast cancer | lymph nodes | N | Surgery | NA |
| Crider et al11 | M | 59 | Lung cancer | Pancreas | N | HU | DOM |
| Tamiolakis et al12 | M | 62 | Colon cancer | Liver | Y | None | NA |
| Du et al13 | M | 57 | Prostate cancer | Spleen | N | None | NA |
| Hsu et al14 | F | 64 | Lung cancer | Paraspinal region | N | None | NA |
| Millar et al15 | F | 36 | Breast cancer | lymph nodes | N | None | NA |
| Yang et al16 | F | 73 | Breast cancer | Mesenterium | Y | None | NA |
| Talmon et al17 | F | 49 | Renal cancer | Kidney | N | Surgery | NA |
| Celik et al18 | F | 69 | Renal cancer | Kidney | N | Surgery | NA |
| Orphanidou-Vlachou et al19 | F | 55 | Renal cancer | Kidney | N | Surgery | NA |
| Tamm et al20 | M | 53 | CBCC | Liver | Y | Surgery | NA |
| Arkadopoulos et al21 | F | 75 | Breast cancer | Adrenal gland | N | Surgery | NA |
| Groisman et al22 | F | 49 | Breast cancer | Spleen | N | Surgery | SD |
| Dekmezian et al23 | F | 1 | Liver cancer | Liver | N | Surgery | DOM |
| Dekmezian et al23 | F | 3 | Liver cancer | Liver | N | Surgery | NA |
| Paydas et al24 | M | 52 | Lung cancer | Paraspinal region | Y | None | NA |
| Chou et al25 | F | 50 | Colon cancer | Kidney | N | Surgery | NA |
| Lewis et al26 | M | 71 | Renal cancer | Kidney | N | Surgery | SD |
| Varras et al27 | F | 40 | Breast cancer | Endometrium | N | Surgery | NA |
| Lara et al28 | NA | NA | Lung cancer | Bronchia | Y | None | NA |
| Policarpio-Nicolas et al29 | M | 68 | Lung cancer | Spleen | N | None | NA |
| Zorn et al30 | M | 62 | Renal cancer | Ureter | N | Surgery | NA |
| Bosco et al31 | F | 84 | Bladder cancer | Paraspinal region | N | None | SD |
| Wright et al32 | F | 66 | EC | Presacral region | Y | None | NA |
| Vassiliou et a33 | F | 65 | Colon cancer | Presacral region | N | None | SD |
| Williamson et al34 | M | 81 | Renal cancer | lymph nodes and kidney | Y | Surgery | NA |
| Makoni et al35 | M | 36 | melanoma | Liver, spine and lymph nodes | N | None | DOM |
Abbreviations: CBCC, cutaneous basal cell carcinomas; DOM, died of malignancy; EAS, endometrial adenosarcoma; EC, endometrial cancer; F, female; M, male; N, no; NA, not available; NPC, nasopharyngeal carcinoma; OEC, ovarian endometrioid adenocarcinoma; OLMS, ovarian leiomyosarcoma; SD, stable disease; Y, yes; EMH, extramedullary hematopoiesis; HU, hydroxyurea.